Blood test may predict insulin need in pregnancy diabetes
NCT ID NCT02159378
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether measuring fructosamine levels in the blood can help predict which women with gestational diabetes will need insulin. Researchers enrolled 200 pregnant women and measured their fructosamine levels. The goal was to see if this test could guide treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fructosamines (blood test)
- What this could lead to
- If successful, this could help doctors predict which women with gestational diabetes will need insulin, allowing earlier treatment.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. Fructosamine is not a proven predictor, and results may not change practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier départemental Vendée
La Roche-sur-Yon, 85925, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a class tame pregnancy stress at the genetic level?
- A nationwide test: do home visits build healthier families?
- Can a simple calcium tablet help prevent postpartum bleeding?
- Can AI read ultrasound sweeps to tell Baby's position?
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes
- Could a smart ring unlock secrets of pregnancy health?